Axona is Accera’s new product for people with mild to moderate Alzheimer’s. Available in the U.S. by prescription only, Axona is marketed as a medical food. This means it was not subject to FDA pre-market review and approval. Results of the company’s trials of Axona sound promising, but we’ll have to wait for more data to be published to get a better idea how effective the product is.
You can read more about it here:
Now this sounds promising….one drink a day to a clearer head!!!
Interests that I’ve put aside. Presently record any interests that you’ve implicitly or unequivocally put aside to do your paper. You may likewise need to consider interests that you’ve put aside for other life requests. PhD Dissertation Writing Services
Axona: A different approach to alzheimersMost popular topics Topics with no replies
Viewing 2 posts - 1 through 2 (of 2 total)